1. Introduction {#sec1-antioxidants-07-00019}
===============

Selenium has been shown to be an essential trace element in all animals. Deficiency of selenium has been linked to several diseases and disorders, including an increased risk of cancer and of cardiovascular and neurological diseases, as well as a decrease in immune function \[[@B1-antioxidants-07-00019],[@B2-antioxidants-07-00019],[@B3-antioxidants-07-00019]\]. Most of the beneficial effects of selenium are due to the existence of a pool of selenoproteins, which are involved in redox biology and homeostasis. In effect, the selenoproteins have the ability to translationally incorporate a rare amino acid residue, selenocysteine (Sec, U), using a specific and complex machinery (for details, see \[[@B4-antioxidants-07-00019]\]). The selenocysteine residue is more reactive and less sensitive to oxidation than its sulfur analog cysteine. At the catalytic site of enzymes, selenocysteine participates in redox reactions, which are essential for antioxidant defense, redox homeostasis, and cell signaling \[[@B5-antioxidants-07-00019],[@B6-antioxidants-07-00019],[@B7-antioxidants-07-00019],[@B8-antioxidants-07-00019]\]. Gene inactivation in mice of certain selenoproteins, such as glutathione peroxidase 4 (Gpx4), thioredoxin reductase 1 (Txnrd1), or SelenoT, leads to embryonic lethality. Therefore, it is comprehensible that gene inactivation of Sec-tRNA^\[Ser\]Sec^ or Selenocysteine insertion sequence binding protein-2 SECISBP2 \[[@B9-antioxidants-07-00019],[@B10-antioxidants-07-00019]\], altering selenoprotein synthesis, is also fatal in mice. The level of selenoprotein expression in the organism is tightly regulated not only by the bioavailability of selenium, but also by exogenous stimuli \[[@B11-antioxidants-07-00019]\]. For in vitro cultured cells, the level of selenium dictates the range of selenoprotein expression in accordance with a cell-line-specific hierarchy \[[@B4-antioxidants-07-00019]\]. The interplay between selenium levels and exogenous stimuli, such as aging or oxidative stress, has only been studied in specific cases \[[@B11-antioxidants-07-00019],[@B12-antioxidants-07-00019],[@B13-antioxidants-07-00019],[@B14-antioxidants-07-00019]\].

Aging is a slow, complex, and multifactorial process, resulting in a gradual and irreversible decline of various functions of the body, making organisms more vulnerable and more likely to die \[[@B11-antioxidants-07-00019]\]. Several cellular aspects of organismal aging are recapitulated in the replicative senescence of cultured human diploid fibroblasts, such as embryonic lung fibroblast WI-38 cells, which thus offer a commonly used cellular model to study in vitro features of the aging phenomenon \[[@B15-antioxidants-07-00019]\]. Cellular senescence, also referred to as replicative senescence, was initially described by Hayflick and Moorehead in 1961 \[[@B16-antioxidants-07-00019]\]. Senescence is defined by the finding that diploid cells go through a finite number of divisions---also referred to as the Hayflick limit \[[@B16-antioxidants-07-00019]\]. Cellular senescence is characterized by an irreversible cell cycle arrest via the p53, pRb, p16, and p21 signaling pathways \[[@B17-antioxidants-07-00019],[@B18-antioxidants-07-00019],[@B19-antioxidants-07-00019]\]; telomere shortening; accumulation of oxidative damage; and several senescence-associated markers, including β-galactosidase (SABG) and heterochromatin foci (SAHF). Interestingly, the number of senescent cells increases with age and senescent-associated phenotypes are considered to be predictive features of age-related phenotypes. In various cell types, premature senescence can be induced by exogenous stimuli. For example, repeated exposure to mild oxidative stress (utraviolet radiation (UV) or tert-Butyl hydroperoxide) provokes a stress-induced premature senescence (SIPS) phenotype \[[@B20-antioxidants-07-00019],[@B21-antioxidants-07-00019],[@B22-antioxidants-07-00019]\] in human diploid fibroblasts. Additionally, in cancer cells, the use of drug therapy can also lead to premature senescence, namely therapy-induced senescence (TIS) \[[@B23-antioxidants-07-00019],[@B24-antioxidants-07-00019]\]. Although, in every case, a G~0~ cell cycle arrest is observed, in general, the molecular mechanisms involved and intracellular targets differ between the different senescence phenotypes.

Even though redox status is implicated in the aging phenotype, the link between selenium and aging or replicative senescence has, so far, been poorly investigated (reviewed in \[[@B11-antioxidants-07-00019]\]). Primarily, it was reported that selenium levels and selenium-dependent glutathione peroxidase activity decreased in the serum of healthy Italian subjects \[[@B25-antioxidants-07-00019]\]. Interestingly, it was observed in this study that the selenium levels in the elderly were much more scattered than those in young persons. It has been suggested that the decrease of selenium status in aging could lead to a weakening of the antioxidant defense and a decrease in longevity, although the molecular mechanisms and selenoproteins involved remain to be identified. At the cellular level, a few studies have reported extension of the replicative lifespan of cultured cells with selenium supplementation \[[@B13-antioxidants-07-00019],[@B26-antioxidants-07-00019]\]. In the most recent study, a 30 nM selenium supplementation of the culture medium significantly reduced the level of senescence markers, including signaling molecules (p16, p21, p53), telomere shortening, SABG and SAHF \[[@B13-antioxidants-07-00019]\]. As a corollary, the expression of several selenoproteins was altered by replicative senescence. In this study, it was found that selenoproteins were regulated at both the transcriptional and translational levels.

In the present study, we have further investigated the interrelation between selenium and replicative senescence at the molecular level using a proteomic approach. We have compared the response to senescence with long-term growth in culture media containing various levels of selenium, previously found to modulate the replicative capacity of WI-38 cells. Due to a large overlap in protein targets, our data favor an action of selenium in the generic replicative senescence pathway, rather than a premature senescence similar to SIPS.

2. Materials and Methods {#sec2-antioxidants-07-00019}
========================

2.1. Cell Growth {#sec2dot1-antioxidants-07-00019}
----------------

Human embryonic fibroblasts WI-38 were purchased from SIGMA (Chicago, IL, United States of America) (passage 15, estimated cumulative population doublings (CPD) 30), grown and maintained in 75 cm^2^ plates in Dulbecco's Modified Eagle Medium (D-MEM) supplemented with 10% fetal calf serum (FCS), 100 µg mL^−1^ streptomycin, 100 UI mL^−1^ penicillin, 1 mM sodium pyruvate, and 2 mM [l]{.smallcaps}-glutamine. Cells were cultivated in 5% CO~2~ at 37 °C and a humidified atmosphere. The different culture media referred to as depleted (Dpl), control (Ctl), and supplemented (Sup) were prepared according to \[[@B13-antioxidants-07-00019]\] and contained, respectively, 3, 15, and 45 nM of selenium, as determined by Inductively coupled plasma-mass spectrometry ICP-MS \[[@B12-antioxidants-07-00019],[@B13-antioxidants-07-00019],[@B27-antioxidants-07-00019],[@B28-antioxidants-07-00019]\]. The quantification of the selenium levels in the raw FCS (150 nM) was obtained with a limit of quantification (LOQ) of 2.5 nM. Although much lower than selenium levels in serum, the concentration of 45 nM in the culture medium yielded a strong increase in protein expression for several selenoproteins when selenite was used to supplement the medium \[[@B13-antioxidants-07-00019]\]. When cells reached confluence (approximately at 100,000 cells per cm^2^), they were passaged in a new flask at 10,000 cells per cm^2^ density. WI-38 cells were counted at each passage to calculate the Population Doubling (PD) using the equation ΔPD = log ((Final Cell Number)/(Initial Cell Number))/log (2). Cumulative PD was plotted as a function of time.

2.2. Protein Extraction. 2D Clean-Up Kit. Protein Quantification. Verification of Protein Quality by SDS PAGE {#sec2dot2-antioxidants-07-00019}
-------------------------------------------------------------------------------------------------------------

All chemical reagents purchased were 2D-DIGE grade (i.e., PlusOne, GEHealthcare, Little Chalfont, United Kingdom). Whole protein extracts were obtained from 75 cm^2^ plates using cell lysis buffer composed of 40 mM Tris-HCl pH 7.8, 8 M urea, 2 M thiourea, 4% (*w/v*) 3-\[(3-Cholamidopropyl)dimethylammonio\]-1-propanesulfonate hydrate (CHAPS), 50 mM DL-Dithiothreitol DTT, and protease inhibitor (Complete Mini, Roche Diagnostics). Cells were disrupted by passing them through a 23 gauge syringe 10 times. The homogenates were centrifuged at 20,000 g for 1 h at 4 °C. The supernatant was collected and conserved at −20 °C. An aliquot of crude protein extract was precipitated and washed according to the 2D clean-up kit procedure (GEHealthcare). Pellets were resuspended in 50 µL of Urea, Thiourea, CHAPS (UTC) buffer (8 M urea, 2 M thiourea, 4% CHAPS). Protein concentrations were measured using the Detergent compatible (DC)kit protein assay kit (Biorad) in microplate assays (BMG Labtech GmbH, Ortenberg, Germany). To verify the integrity of protein extracts and correct quantification of protein concentrations, 5 µg of each sample was separated in Bis-Tris NuPAGE Novex Midi Gels (Life Technologies, Carlsbad, CA, United States of America, under 3-(N-Morpholino)propanesulfonic acid, 4-Morpholinepropanesulfonic acid (MOPS) conditions. The gel was then stained using Coomassie staining solution.

2.3. 2-Dimensional Differential in-Gel Electrophoresis (2D-DIGE) Labeling, Isoelectric Focusing Electrophoresis (IEF), and Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE ) of Protein Samples {#sec2dot3-antioxidants-07-00019}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Four experimental replicates for each set of conditions were collected from cells grown in four individual flasks. As shown in [Figure 1](#antioxidants-07-00019-f001){ref-type="fig"}, six growth conditions were generated, i.e., young Se-depleted (YD), young Se-control (YC), young Se-supplemented (YS), senescent Se-depleted (SD), senescent Se-control (SC), and senescent Se-supplemented (SS). In total, 24 different protein extracts were analyzed using the 2D-DIGE strategy. A quantity of 50 µg of protein from each sample was transferred to a different tube (i.e., 24 in total), and the volume adjusted to 11 µL with UTC buffer. An internal standard (IS) was made by mixing 25 µg of each sample in another tube, with the volume completed to 132 µL with UTC buffer. CyDye DIGE Fluor minimal dyes (GEHealthcare, Little Chalfont, United Kingdom), which react with lysine residues, were resuspended at 400 pM/µL concentration in dimethylformamide (DMF). A quantity of 1 µL of a specific CyDye solution (i.e., Cy3 or Cy5) was add to the 11 µL of protein sample according to the schematic in [Figure 2](#antioxidants-07-00019-f002){ref-type="fig"}A. Biological replicates were randomly labelled to prevent dye bias. On the other hand, 12 µL of Cy2 was added to the 132 µL of internal standard. The labeling reaction was left to occur for 30 min on ice, protected from light. To the Cy3 and Cy5 reactions, 1 µL of DIGE stop solution (10 mM Lysine) was added. On the other hand, 12 µL of DIGE stop solution was added to the Cy2 (IS) reaction. The stop reaction was left to occur for 10 min protected from light at 4 °C. Twelve mixes composed of one Cy3 (13 µL), one Cy5 (13 µL), and 13 µL of the IS (Cy2) reaction were generated according to the table in [Figure 2](#antioxidants-07-00019-f002){ref-type="fig"}A. The volume was completed with 311 µL of isoelectric focusing electrophoresis (IEF) rehydration buffer composed of 8 M urea, 2 M thiourea, 2% (*w/v*) CHAPS, 12 µL/mL DeStreak reagent (GEHealthcare, Little Chalfont, United Kingdom), 0.5% (*v/v*) immobilized pH gradient (IPG) Buffer (3--10 non-linear (NL)), and traces of Bromophenol blue. This solution was loaded onto an 18 cm Immobiline DryStrip (3--10 NL) by passive rehydration under a layer of DryStrip Cover Fluid (GEHealthcare, Little Chalfont, United Kingdom) overnight. Then, IEF was performed using IPGPhor2 (GEHealthcare, Little Chalfont, United Kingdom) with the following run: 150 V for 1 h, 200 V for 1 h, gradient 200--1000 V for 9 h, gradient 1000--8000 V for 3 h, and 8000 V until total volt hours (Vh) reached 35,000. At this stage, the strips were kept frozen at −20 °C until further use.

The strips were thawed and incubated for 12 min in equilibration buffer 1 composed of 50 mM Tris-HCl pH 8.6, 6 M urea, 2% (*w/v*) SDS, 30% (*v/v*) glycerol, and 65 mM DTT. Then, the strips were transferred for 12 min to equilibration buffer 2, composed of 50 mM Tris-HCl pH 8.6, 6 M urea, 2% (*w/v*) SDS, 30% (*v/v*) glycerol, and 250 mM Iodoacteamide. After the equilibration stage, each strip was positioned on top of a 12.5% acrylamide (acrylamide/bis acrylamide, 37.5:1) SDS-PAGE and run overnight using the Ettan DALTII system (GEHealthcare, Little Chalfont, United Kingdom), allowing the simultaneous migration of six gels. Migration conditions were as follows: 15 W per gel for 30 min, and 25 W per gel for 16 h, under a water cooling system. It should be noted that the gels were cast in low-fluorescence glass plates to allow a direct reading with a Typhoon fluorescence scanner.

2.4. Fluorescence Scanning of the Gel and Decyder Analysis {#sec2dot4-antioxidants-07-00019}
----------------------------------------------------------

After the second-dimension electrophoresis run, the plates containing the gels were carefully cleaned and directly scanned with a Typhoon FLA 9500 (GEHealthcare, Little Chalfont, United Kingdom), without uncasting the gel. The orientation of the plates was kept identical for the 12 gels. Every gel was scanned three times with the following parameters: for Cy2, laser 488 nm, emission filter 520BP40, photomultiplier voltage setting (PMT) 490; for Cy3, laser 532 nm, emission filter 580BP30, PMT 520; for Cy3, laser 633 nm, emission filter 670BP30, PMT 470. Importantly, the scanning parameters were kept identical for the 12 gels with a resolution set at 100 µm. The data analysis, including the principal component analysis (PCA), was performed with Decyder 7.0 software (GEHealthcare, Little Chalfont, United Kingdom) according to the manufacturer's instructions.

2.5. Mass Spectrometry Protein Analysis {#sec2dot5-antioxidants-07-00019}
---------------------------------------

### 2.5.1. Sample Preparation {#sec2dot5dot1-antioxidants-07-00019}

A preparative gel was formed with 500 µg of protein completed with rehydration buffer to a total of 340 µL. Rehydration, migration of the strips, and SDS-PAGE were performed as described earlier for the fluorescence-labeled samples. Each spot of interest was localized in the Coomassie-stained 2D-gel, excised, and subjected to enzymatic digestion. Trypsin digestion of selected spots was performed following reduction/alkylation of cysteine residues as described previously \[[@B29-antioxidants-07-00019]\] with the addition of 10 µL of trypsin (12.5 ng/µL) per spot and 20 µL of extraction solvent for peptide extraction. Tryptic peptides were vacuum-dried and finally resuspended in 0.1% formic acid and 5% acetonitrile before nanoscale liquid chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS) analyses.

### 2.5.2. NanoLC-MS/MS Analyses {#sec2dot5dot2-antioxidants-07-00019}

Tryptic peptides were analyzed by nanoLC-MS/MS analysis using first a nanoAcquity liquid chromatograph (Waters, Milford, MA, United States of America) coupled to a quadrupole-time-of-flight (Q-TOF) Premier mass spectrometer (Waters, Milford, MA, United States of America), and secondly an EASY-nLC II HPLC system (Proxeon, ThermoScientific, Waltham, MA, United States of America) coupled to a nanoESI-Linear Trap Quadropole (LTQ)-Orbitrap Velos mass spectrometer (Thermo Scientific) in case no significant protein identification was obtained in the first analysis. Nano-liquid chromatography elution conditions were similar for both systems, operated with a flow rate of 300 nL/min and an acetonitrile gradient of 5--40% (*v/v*) over 20 min. The nanoLC system (Waters, Milford, MA, United States of America) coupled to the Q-TOF Premier was equipped with a trapping column (C18 symmetry, 180 μm × 20 mm, particle size 5 μm, from Waters) and an analytical column (BEH 130 C18, 75 μm × 100 mm, particle size 1.7 μm, from Waters). In the Q-TOF analysis, MS/MS spectra were acquired by a data-dependent acquisition method involving selection of the three precursors giving the most intense signals. Raw data acquired on the Q-TOF were processed with a ProteinLynx Global Server (Waters). For proteins identified with less than two peptides, the tryptic peptide samples were further analyzed on the more sensitive LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). In the nanoLC system coupled to the LTQ-Orbitrap, peptide separation was performed on a reversed-phase C18 nanoHPLC column (100 µm inner diameter, 5 µm C18 particles, 15 cm length, NTCC-360/100-5, from NikkyoTechnos (NikkyoTechnos Co., Tokyo, Japan). For the LTQ-Orbitrap, MS/MS spectra were acquired using the data-dependent acquisition mode operating with a Top20 collision induced dissociation (CID) method: the mass of the precursors was measured with high resolution (60,000 full width at half maximum (FWHM)) in the Orbitrap and the twenty most intense ions, above an intensity threshold of 5000 counts, were selected for Collision-Induced Dissociation (CID) fragmentation and analysis in the LTQ. Raw data acquired with the LTQ-Orbitrap were processed with Proteome Discoverer 1.3 software (Thermo Fisher Scientific, Waltham, MA, United States of America).

### 2.5.3. Protein Identification {#sec2dot5dot3-antioxidants-07-00019}

Proteins were identified using the MASCOT search engine (Matrix Science, London, UK) against the Swissprot 0112 database with carbamidomethylation of cysteines set as a fixed modification, and oxidation of methionines as variable modifications. Peptide and fragment mass tolerances were set at 20 ppm and 0.1 Da, respectively, for Q-TOF data, and at 5 ppm and 0.6 Da, respectively, for Orbitrap data. Only proteins identified with at least two peptides with a score higher than the identity threshold calculated at a false discovery rate of less than 1% (Mascot decoy option) were considered. The generated protein lists were analyzed with the use of Ingenuity Pathways Analysis™ software (QIAGEN Inc., Available Online: <https://www.qiagenbioinformatics.com/>).

3. Results {#sec3-antioxidants-07-00019}
==========

3.1. 2-Dimensional Differential in-Gel Electrophoresis (2D-DIGE) and Mass Spectrometry Identification of Protein Spots {#sec3dot1-antioxidants-07-00019}
----------------------------------------------------------------------------------------------------------------------

Replicative senescence is characterized by a finite number of cell divisions under defined growth conditions. We have recently shown that selenium levels in the culture medium modulated the proliferative capacity of WI-38 \[[@B13-antioxidants-07-00019]\]. In other words, selenium supplementation (Sup) significantly increased the number of cell divisions and decreased the senescence-associated markers and phenotypes, in comparison with control (Ctl) conditions. On the other hand, selenium deficiency (Dpl) accelerated entry into senescence and reduced the proliferative capacity of WI-38 cells, measured by the population doubling at each passage. This acceleration of the senescence-associated phenotype coincides with the decrease in selenoproteins involved in antioxidant defense, glutathione peroxidase 1 (Gpx1) and glutathione peroxidase 4 (Gpx4). Experimentally, at CPD 35.8, mitotically active WI-38 cells, initially grown in Ctl medium, were plated in three different conditions, namely Dpl, Ctl, and Sup. After two passages, young WI-38 cells grown in the different culture media were harvested, at CPD 39.7, 40.4, and 41.9, respectively, from four experimental replicates, and referred to as Young Dpl, Ctl, and Sup (YD, YC, and YS, respectively). As previously observed, even after two passages of young cells in various selenium-containing media, a difference of cell proliferation could be noticed. In parallel, additional flasks were maintained in respective media and harvested (again in four experimental replicates) when they reached presenescent stage, at CPD 48.7, 54.7, and 57.6, respectively, and were referred to as senescent Dpl, Ctl, and Sup (SD, SC, and SS, respectively), see [Figure 1](#antioxidants-07-00019-f001){ref-type="fig"}.

A proteomic study was then applied to our samples. Comparison of expression patterns between our six different cell growth conditions was performed using 2D-DIGE methodology ([Figure 2](#antioxidants-07-00019-f002){ref-type="fig"}A), which displays additional advantages compared with classical 2D-gel proteomic analyses. We took advantage of the high resolution of the 2D-gel electrophoresis that allows the separation of proteins as spots according to their isoelectric point (pI) in the first dimension, and their molecular weight in the second dimension. This technique is particularly efficient to separate protein isoforms with different posttranslational modifications (PTMs). The CyDye fluorescent minimal labeling provides at least the same sensitivity as protein silver staining, but with a much higher dynamic range for quantification. Usually, 2500 protein spots can be mapped in a typical 2D-gel from a whole cell extract. An important feature of the 2D-DIGE methodology is the use of an internal standard in all gels, which allowed a reliable spot assignment between the 12 different gels and a precise inter-gel spot quantification. The scanned images were analyzed with Decyder 7.0 software (GEHealthcare). Six groups, namely YD, YC, YS, SD, SC, and SS were assigned to the various scans, each group being composed of four replicates. The gel images were treated with an exclusion volume filter of 30,000 to remove artifacts from the analyses. A master gel was identified by the software, with 2499 spots. Among this number of spots in the master gel, 1155 spots were found in 80% of the gel maps (i.e., 32 out of 36), and were used for further analyses. In order to validate the quality of the replicates, and, if necessary, remove an outlier replicate from the analysis, we performed a principal component analysis (PCA). In effect, when we applied a statistical filter to the spot maps (one-way analysis of variance (ANOVA) \< 0.01), we were able to cluster the 2D protein profiles into six groups of four replicates ([Figure 2](#antioxidants-07-00019-f002){ref-type="fig"}B) corresponding to our six experimental conditions. The first component separated the protein profiles according to the number of passages (young vs. senescent cells, principal component 1 (PC1): 52% of total variation), while the second dimension differentiated the sample according to the selenium variation (Dpl, Ctl vs. Sup, principal component 2 (PC2): 20.7% of total variation). This statistical analysis indicated that protein expression was more impacted by senescence phenotype than by selenium variation, which seemed to be more subtle. In addition, it appeared that SD, SC, and SS were much more segregated than YD, YC, and YS, indicating that the selenium levels of the culture medium induced more differences in protein expression in senescent than in young cells. When considering only young and senescent cells grown in control medium, YC and SC, respectively, the segregation between the two groups was also obvious with PCA ([Figure 2](#antioxidants-07-00019-f002){ref-type="fig"}C).

When we applied specific filters for differentially and significantly expressed proteins (±50% and *t*-test \< 0.05), we found 136 spots among the 1155 common to 80% of the spot maps. In other words, the expression of almost 12% of the proteome was affected by either replicative senescence and/or selenium levels of the culture media. In the preparative gel stained with Coomassie staining, only 81 spots were noticeable (see [Figure 3](#antioxidants-07-00019-f003){ref-type="fig"}). These protein spots were collected and sent for mass spectrometry protein identification and peptide match search with the human proteome databank as described in Materials and Methods. Basically, protein identification was performed after trypsin digestion with a Q-TOF mass spectrometer, except when two or less peptides were identified by MS/MS. In these cases, the remaining tryptic digestion was analyzed with an Orbitrap mass spectrometer, which provided more peptide sequences than the Q-TOF analysis. Among the 81 spots, 123 proteins were identified. The list of identified proteins together with the mass spectrometer used are indicated in [Table 1](#antioxidants-07-00019-t001){ref-type="table"}. Three lists of proteins of interest were generated: (i) proteins differentially regulated between YC and SC (±50% and *t*-test \< 0.05, see [Table S1](#app1-antioxidants-07-00019){ref-type="app"}); (ii) proteins differentially regulated between YD and YS (same cut-off parameters, see [Table S2](#app1-antioxidants-07-00019){ref-type="app"}); (iii) proteins differentially regulated between SD and SS (same cut-off parameters, see [Table S3](#app1-antioxidants-07-00019){ref-type="app"}). The proteins common to at least two lists are presented in [Table S4](#app1-antioxidants-07-00019){ref-type="app"}. Typical examples of differentially regulated proteins are shown in [Figure 4](#antioxidants-07-00019-f004){ref-type="fig"}, for spots number 2202, 1734, and 1869, respectively.

3.2. Effect of Senescence in Ctl Conditions {#sec3dot2-antioxidants-07-00019}
-------------------------------------------

Many proteomic studies have investigated the phenotype of premature senescence, induced either by drug therapy (TIS) or by repeated exposure to mild oxidative stress (SIPS), but very few have investigated the replicative senescence of human diploid cells, such as WI-38 \[[@B22-antioxidants-07-00019],[@B30-antioxidants-07-00019],[@B31-antioxidants-07-00019]\]. From a comparative study, it appeared that SIPS, TIS, and replicative senescence have distinct phenotypes but limited protein targets and pathways in common \[[@B22-antioxidants-07-00019]\]. In this study, the authors found 50 spots with significant differences (±30% and *t*-test \< 0.05) between young and senescent cells. Among these 50 spots, 12 were common with two different models of SIPS, suggesting that partially distinct mechanisms are involved. Unfortunately, in this study, the proteins were not identified by mass spectrometry. Here, our analysis---performed with slightly different parameters (±50% and *t*-test \< 0.05)---allowed the detection of 43 spots, differentially regulated between young and senescent cell extracts, from which 71 proteins were identified by mass spectrometry (see [Table 1](#antioxidants-07-00019-t001){ref-type="table"} and [Table S1](#app1-antioxidants-07-00019){ref-type="app"}). Interestingly, we found three times more proteins whose expression was stimulated in senescent compared to young cells than we did downregulated proteins. Among the most upregulated proteins, we found prohibitin-2 (PHB2), 78 kDa glucose-regulated protein (HSP5A), the cytoplasmic malate dehydrogenase (MDH1), heat shock cognate 71 kDa protein (HSPA8), and Vinculin (VCL), in spots 1546, 789, 1500, 761, and 754, respectively (see [Figure 3](#antioxidants-07-00019-f003){ref-type="fig"} for spot location). In contrast, several proteins were found to be downregulated during replicative senescence, including the cytosolic superoxide dismutase (SOD1), the mitochondrial heat shock protein 75 kDa (TRAP1), the serine-threonine kinase receptor-associated protein (STRAP), and Vimentin (VIM) ([Table 1](#antioxidants-07-00019-t001){ref-type="table"} and [Table S1](#app1-antioxidants-07-00019){ref-type="app"}). In principle, 2D DIGE allowed the detection of approximately 2500 spots which represent at maximum only 5 to 10% of the proteome, typically the most abundant proteins. It follows that most of the information regarding low abundance proteins is missing. To uncover the molecular pathways that are affected by replicative senescence of other potentially identifiable targets of this phenotype, we performed an Ingenuity^®^ Pathway Analysis (IPA^®^) on the list of significantly differentially expressed proteins ([Table 2](#antioxidants-07-00019-t002){ref-type="table"}). This analysis proposed the three most relevant networks, which were (i) free radical scavenging, molecular transport, cancer; (ii) developmental disorders, and neurological and inherited diseases; and (iii) cancer, neurological disease, and cell signaling. The best-represented network in terms of number of members identified by mass spectrometry is shown in [Figure 5](#antioxidants-07-00019-f005){ref-type="fig"}A. These data suggest that the free radical scavenging pathway is a target of replicative senescence in WI-38 cells, making relevant the impact of selenium in slowing down the senescence phenotype by improving antioxidant status and redox homeostasis.

3.3. Effect of Selenium on Young and Presenescent Cells {#sec3dot3-antioxidants-07-00019}
-------------------------------------------------------

A similar analysis was performed to identify the proteins that were affected by selenium levels in either young or senescent cells. A cut-off of ±50% change in protein expression between Sup and Dpl with a *t*-test \< 0.05 was applied. Spots 12 and 63 fulfilled these criteria in young and senescent conditions, respectively. The proteins identified by MS are listed in [Table 1](#antioxidants-07-00019-t001){ref-type="table"} and in [Tables S2 and S3](#app1-antioxidants-07-00019){ref-type="app"}. Among these differentially expressed spots, 12 (young) and 70 (senescent) proteins were identified by mass spectrometry. It appears that selenium levels have much more impact in senescent than in young cells. In addition, the overlap of selenium-dependent variations between young and senescent cells is rather limited, as illustrated in the Venn diagrams in [Figure 6](#antioxidants-07-00019-f006){ref-type="fig"}. In the list of identified proteins regulated by selenium levels in senescent cells, we found 78 kDa glucose-regulated protein (HSPA5), Vinculin (VCL), Desmoplakin (DSP), Gelsolin (GSN), and Heat shock protein 70 kDa (HSPA1A) among the most upregulated proteins in Sup conditions. Among the most downregulated proteins in Sup conditions, we identified Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), Phosphoglycerate mutase 1 (PGAM1), Peroxiredoxin-6 (PRDX6), and Endoplasmic reticulum resident protein 29 (ERP29). An Ingenuity^®^ Pathway Analysis was then performed on the list of significantly differentially expressed proteins upon selenium variation ([Table 3](#antioxidants-07-00019-t003){ref-type="table"}). This analysis proposed the three most relevant networks, namely: (i) immune, inflammatory, and hematologic diseases; (ii) cellular function and maintenance, energy production, lipid metabolism; and (iii) cancer, neurological diseases, and cell signaling. The first network, which is composed of 21 identified members, is shown in [Figure 5](#antioxidants-07-00019-f005){ref-type="fig"}B to illustrate the various connections of the network with associated groups or molecules.

3.4. Intersection between Selenium and Senescence {#sec3dot4-antioxidants-07-00019}
-------------------------------------------------

In order to determine whether the impact of selenium levels on the replicative potential of WI-38 fibroblasts involves similar pathways to regular senescence as suggested in \[[@B13-antioxidants-07-00019]\], we investigated the overlap between the differentially expressed proteins listed in [Tables S1--S3](#app1-antioxidants-07-00019){ref-type="app"}. As inferred by the Venn diagrams, the common targets encompassed 31 spots ([Figure 6](#antioxidants-07-00019-f006){ref-type="fig"}A), from which 44 proteins were identified by mass spectrometry ([Figure 6](#antioxidants-07-00019-f006){ref-type="fig"}B and [Table S4](#app1-antioxidants-07-00019){ref-type="app"}). Our data show that 72% of the variation observed between young and senescent cells (31 spots over 43) are common with the response to selenium level variation. This value strongly suggests that the change of selenium levels in the culture affects predominantly molecular pathways linked to replicative senescence and may not be related to a premature senescence phenotype like TIS or SIPS. The link between selenium and senescence is illustrated by several selected examples in [Figure 6](#antioxidants-07-00019-f006){ref-type="fig"}, namely, spots 2202, 1734, and 1869, identified as Superoxide dismutase Cu-Zn (SOD1), Prohibitin-1 (PHB), and Ubiquitin carboxyl hydrolase terminal (UCHL1), respectively. Spot 1869 (UCHL1) is a common target of senescence, selenium in young cells, and selenium in senescent cells. As shown in [Figure 4](#antioxidants-07-00019-f004){ref-type="fig"}C and [Table 1](#antioxidants-07-00019-t001){ref-type="table"}, this protein is upregulated by selenium depletion (+51% in young and +134% in senescent cells) and in response to senescence (+54%). Interestingly, selenium supplementation seemed to counteract this upregulation in senescent cells. It is tempting to speculate that UCHL1 and thence the connected pathway of proteasome protein degradation were affected immediately after selenium changes in the culture media, and that this effect lasted up to the senescence stage. Interestingly, the level of spot 1869 in SS conditions was almost identical to that in young cells (YC). On the other hand, spot 2202 (SOD1) exemplifies the opposite situation ([Figure 4](#antioxidants-07-00019-f004){ref-type="fig"}A), where a downregulation of the protein occurred during replicative senescence (−118%) and selenium deficiency (−174% in senescent cells). This effect was counteracted in senescent cells by selenium supplementation to recover an almost identical level as that of young cells (compare SS with YC conditions in [Figure 4](#antioxidants-07-00019-f004){ref-type="fig"}A). Interestingly, the downregulation of this spot seemed to also occur at early passages in Dpl medium, suggesting an early event that could initiate the senescence phenotype. Another kind of regulation is exemplified by spot 1734 (PHB, [Figure 4](#antioxidants-07-00019-f004){ref-type="fig"}B), which is upregulated (+76%) during the senescence process and by selenium deficiency in senescent cells (63%). Similar to UCHL1 and SOD1, the level of PHB in selenium-supplemented senescent cells (SS) almost reached that of the young conditions (YC), again suggesting a mechanism for the selenium-dependent slow-down of the senescence phenotype. It is important to bear in mind that protein content does not always correlate with enzyme activity. Most enzymes are subjected to PTMs that can alter catalytic activity. Such PTMs are often visible on 2D-Gel electrophoresis. It will be necessary to further characterize PTM changes in identified targets of selenium and/or senescence.

4. Discussion {#sec4-antioxidants-07-00019}
=============

Our work has consisted of further investigating the initial findings of \[[@B13-antioxidants-07-00019]\], who reported an acceleration of replicative senescence in WI-38 cells due to selenium deficiency. However, selenium supplementation of the culture media was found to improve the replicative potential of WI-38 cells via the p21, p16, p53, and Rb pathways and to reduce senescence-associated markers (SABG, SAHF, telomere shortening). Here, we have used a proteomic approach to study whether this phenotype was relevant to mechanisms implied in premature senescence, induced by repeated stress (SIPS) or by therapy (TIS), or shared common features with the generic replicative senescence phenotype. The proteomics approach used here is based on separation of the cellular proteome in 2D-gels, fluorescent labelling of the proteins allowing a high sensitivity, and reliable data for inter-gel quantitative comparison. In this work, we detected 43 spots differentially and significantly regulated between young and senescent WI-38 cell extracts grown in Ctl conditions. From these spots, 71 proteins were identified by mass spectrometry (Q-TOF or Orbitrap). We compared this set of proteomic data to that obtained by growing WI-38 in various selenium-containing media for two passages or until they reached the senescence stage. We found that the 2D spots differentially expressed in response to replicative senescence variation share a 72% overlap with the spots of interest (31 spots over 43) identified in response to selenium level variation. Our data strongly suggest that selenium variation interferes with the generic senescence program but not with the premature senescence induced by exogenous stimuli. These data further confirm the strong interplay between selenium level and replicative senescence. This is in agreement with the finding that reactive oxygen species (ROS) are increased in senescent cells, together with a reduction of antioxidant defense and cell metabolism \[[@B4-antioxidants-07-00019]\]. We posit a hypothesis stipulating that most of the physiological effect of selenium is due to the activity of selenoproteins involved in redox cellular homeostasis and intracellular ROS levels. Selenoproteins are indeed highly responsive to selenium variation following a gene-specific prioritization of selenium incorporation in selenocysteine, also referred to as the selenoprotein hierarchy \[[@B32-antioxidants-07-00019]\]. This phenomenon has been described in WI-38 cells and found to be involved in transcriptional and translational regulatory mechanisms. To further understand the causal role of selenoproteins in replicative senescence, it will be crucial to follow the impact of gene inactivation of each member of this group of proteins in the acceleration of the senescence phenotype as has been done for several other markers of senescence. For example, the gene inactivation of SOD1, which we found to be downregulated in senescent WI-38 cells, leads to induction of the senescence phenotype \[[@B33-antioxidants-07-00019]\]. Similar strategies could be employed for selenoproteins by targeting individual members or factors involved in their biogenesis \[[@B4-antioxidants-07-00019]\]. To date, a single work has reported the impact of selenoprotein knockdown, in this case, SelenoH (also known as SelH), in human MRC-5 fibroblasts \[[@B34-antioxidants-07-00019]\]. The authors describe a rapid enhancement of senescence-associated markers---including SABG ROS levels and cell autofluorescence---and a decrease in proliferative capacity. The fact that selenoproteins were not found in this proteomic analysis is rather surprising, since they were found to be highly sensitive to selenium variation in a previous study using this cell line. A reasonable explanation could be that the selenoproteome is present at trace levels within the overall proteome. Even the most abundant selenoproteins such as Gpx1 and Gpx4 seemed to be expressed below the detection limits of the CyDye strategy. We would suggest the use of a selenium-specific detection strategy such as (i) radioactive ^75^Se labelling, followed by autoradiography \[[@B35-antioxidants-07-00019]\] or (ii) nonradioactive selenium labeling and detection by elemental mass spectrometry \[[@B36-antioxidants-07-00019],[@B37-antioxidants-07-00019]\]. Alternatively, a state-of-the-art label-free proteomic strategy may also offer a better proteome recovery. Interestingly, glutathione peroxidases were found in the Ingenuity Pathway Analysis, as illustrated in [Figure 5](#antioxidants-07-00019-f005){ref-type="fig"}B.

5. Conclusions {#sec5-antioxidants-07-00019}
==============

Our present work further specifies the action of selenium in replicative senescence of human diploid cells. Our data, from a proteomic perspective, indicate that a significant proportion of the proteins altered by senescence are at least partially counteracted by selenium supplementation, which could explain the improvement of the replicative potential and the reduction of senescence-associated markers observed in our previous work \[[@B13-antioxidants-07-00019]\]. This study opens the path to selective characterization of selenoproteins in the mechanism of replicative senescence and, more globally, the mechanism of aging.
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ACTA1: Actin, alpha skeletal muscle; ACTB: Actin, cytoplasmic 1; ACTG1: Actin, cytoplasmic 2; AkT: RAC serine/threonine-protein kinase; ALDH2: Aldehyde dehydrogenase, mitochondrial; ALDOA: Fructose-bisphosphate aldolase A; ANXA1: Annexin A1; ANXA2: Annexin A2; ANXA4: Annexin A4; ANXA5: Annexin A5; Ap1: Activator protein 1; ARF1: ADP-ribosylation factor 1; ARPC5: Actin-related protein 2/3 complex subunit 5; BLVRA: Biliverdin reductase A; BLVRB: Biliverdin reductase B; CALD1: Caldesmon; CAT: Catalase; CD3: T-cell surface glycoprotein CD3; CENPI: Centromere protein I; CEP104: Centrosomal protein of 104 kDa; CFL1: Cofilin-1; CTSD: Cathepsin D; DES: Desmin; DSP: Desmoplakin; ECH1: Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial; EEF2: Elongation factor 2; EIF2B2: Translation initiation factor eIF-2B subunit beta; EIF4A1: Eukaryotic initiation factor 4A-I; ERK1/2: Extracellular signal-regulated kinase 1/2; ERP29: Endoplasmic reticulum resident protein 29; ETFA: Electron transfer flavoprotein subunit alpha, mitochondrial; FAM189B: Family with sequence similarity 189, member B; FH: Fumarate hydratase, mitochondrial; FRY: Furry homolog; FSH: follicle- stimulating hormone; FTL: Ferritin light chain; G6PD: Glucose-6-phosphate 1-dehydrogenase; GANAB: Neutral alpha-glucosidase AB; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; GARS: Glycyl-tRNA synthetase; GARS: Glycyl-tRNA synthetase; GIPC1: PDZ domain-containing protein GIPC1; GNB2L1: Guanine nucleotide-binding protein subunit beta-2-like 1; GSN : Gelsolin; GSTP1: Glutathione S-transferase P; HEXB: Beta-hexosaminidase subunit beta; HIBCH: 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial; HSPA1A: Heat shock protein 70 kDa; HSPA5: 78 kDa glucose-regulated protein; HSPA8: Heat shock protein 71 kDa; HSPA9: Stress-70 protein, mitochondrial; HSPB1: Heat shock protein beta-1; HSPB6: Heat shock protein beta-6; IDH1: Isocitrate dehydrogenase \[NADP\] cytoplasmic; IL22R1-IL10R2: Interleukin-22 receptor subunit alpha-1, Interleukin-10 receptor subunit beta; IMMT: Mitochondrial inner membrane protein; INPP4B: Type II inositol 3,4-bisphosphate 4-phosphatase; Jun-GABP: Jun, GA-binding protein subunit beta-1; LDHB: L-lactate dehydrogenase B; LEMD2: LEM (lamina-associated polypeptide-emerin-MAN1) domain containing 2; Lh complex: Light-harvesting complex; LMNA: Prelamin-A/C; Mapk: Mitogen-activated protein kinase; MAT2B: Methionine adenosyltransferase 2 subunit beta; MDH1: Malate dehydrogenase, cytoplasmic; MDH2: Malate dehydrogenase, mitochondrial; NANS: Sialic acid synthase; NFkB: Nuclear factor NF-kappa-B; NNMT: Nicotinamide N-methyltransferase; NR2F6: Nuclear receptor subfamily 2 group F member 6; NUDT6: Nucleoside diphosphate-linked moiety X motif 6; P38 MAPK: Mitogen-activated protein kinase 14; P4HB: Protein disulfide-isomerase; PDCD6IP: Programmed cell death 6-interacting protein; PDGF BB: Platelet-derived growth factor subunit B; PDIA3: Protein disulfide-isomerase A3; PEPD: Xaa-Pro dipeptidase; PGAM1: Phosphoglycerate mutase 1; PHB: Prohibitin; PHB2: Prohibitin-2; Pkc: Protein kinase C; PKM2: Pyruvate kinase isozymes M1/M2; POTEE: POTE ankyrin domain family member E; PPA1: Inorganic pyrophosphatase; PRDX2: Peroxiredoxin-2; PRDX6: Peroxiredoxin-6; PSAT1: Phosphoserine aminotransferase; PSMD14: 26S proteasome non-ATPase regulatory subunit 14; PSME4: Proteasome activator complex subunit 4; PTCD2: Pentatricopeptide repeat-containing protein 2, mitochondrial; Rb: Retinoblastoma; RCN1: Reticulocalbin-1; RNH1: Ribonuclease inhibitor; S100A16: Protein S100-A16; SBSN: Suprabasin; SDCBP: Syntenin-1; SET: Protein SET; SLC26A6: Solute carrier family 26 member 6; SLC9A6: Sodium/hydrogen exchanger 6; SMS: Spermine synthase; SOD1: Superoxide dismutase \[Cu-Zn\]; SOD2: Superoxide dismutase \[Mn\], mitochondrial; SPRED3: Sprouty-related, EVH1 domain-containing protein 3; STRAP: Serine-threonine kinase receptor-associated protein; TALDO1: Transaldolase; TBCE: Tubulin-specific chaperone E; TRAP1: Heat shock protein 75 kDa, mitochondrial; TUBB: Tubulin beta chain; TUBB4B: Tubulin beta-4B chain; TUBB6: Tubulin beta-6 chain; UBC: Ubiquitin C; UCHL1: Ubiquitin carboxyl-terminal hydrolase isozyme L1; USP35: Ubiquitin carboxyl-terminal hydrolase 35; USP40: Ubiquitin carboxyl-terminal hydrolase 40; VCL: Vinculin; VIM: Vimentin; Ybx1-ps3: Nuclease-sensitive element-binding protein 1-like

![The replicative life span of WI-38 cells is affected by the selenium level of the culture medium. At cumulative population doublings (CPD) 35.8, WI-38 cells were plated in three different conditions, namely, Se-deficient (Dpl, black dots), Se-control (Ctl, blue square), and Se-supplemented (Sup, red square) for two passages and until they reached the senescent stage. The gray ellipses illustrate the time and stage the cells were harvested for 2-Dimensional Differential in-Gel Electrophoresis (2D-DIGE) analyses.](antioxidants-07-00019-g001){#antioxidants-07-00019-f001}

![Experimental design and statistical validation of our 2D-DIGE analyses. YD: young Se-depleted; SD: senescent Se-depleted; SC: senescent Se-control; YC: young Se-control; SS: senescent Se-supplemented; YS: young Se-supplemented; MS: mass spectrometry; PCA: principal component analysis; PC1: principal component 1; PC2: principal component 2.](antioxidants-07-00019-g002){#antioxidants-07-00019-f002}

![Spot position of the proteins of interest in the spot map of a blue-stained preparative 2D-gel. A quantity of 500 µg of protein sample was separated on a 2D-gel. The identified spots were excised and sent for mass spectrometry identification.](antioxidants-07-00019-g003){#antioxidants-07-00019-f003}

![Typical examples of 2D spots differentially regulated by senescence and selenium levels of the culture media. Respective spot maps in 2D (top panels) and 3D (bottom panel) and average quantification (right graphs) are shown for spots number 2202 (**A**), 1734 (**B**), and 1869 (**C**).](antioxidants-07-00019-g004){#antioxidants-07-00019-f004}
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Illustration of the top networks identified by Ingenuity Pathway Analysis for the response to senescence (**A**) and selenium level variation (**B**). ACTA1: Actin, alpha skeletal muscle; ACTG1: Actin, cytoplasmic 2; ALDH2: Aldehyde dehydrogenase, mitochondrial; aldo: aldolase; ANXA1: Annexin A1; ANXA4: Annexin A4; ANXA5: Annexin A5; APA: Aminopeptidase A; Arp2/3: Actin-related protein 2/3; ARPC2: Actin-related protein 2/3 complex subunit 2; ARPC5: Actin-related protein 2/3 complex subunit 5; ARPC5L: Actin-related protein 2/3 complex subunit 5-like protein; BLVRA: Biliverdin reductase A; CASP8AP2: Caspase-8-associated protein 2; CAT: Catalase; CTSD: Cathepsin D; DES: Desmin; ERK1/2: Extracellular signal-regulated kinase 1/2; ERP29: Endoplasmic reticulum resident protein 29; FDXR: Ferredoxin reductase; G6PD: Glucose-6-phosphate 1-dehydrogenase; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; GNB2L1: Guanine nucleotide-binding protein subunit beta-2-like 1; GSTP1: Glutathione S-transferase P; hCG: Human chorionic gonadotropin; HSP: Heat shock protein; HSP27: Heat shock protein beta-1; HSPB1: Heat shock protein beta-1; HSPB6: Heat shock protein beta-6; LDL: Beta Lipoprotein; Lh: Light-harvesting complex; LMNA: Prelamin-A/C; Nfat: Nuclear factor of activated T-cells; NKkB: Nuclear factor NF-kappa-B; P38 MAPK: Mitogen-activated protein kinase 14; P4HB: Protein disulfide-isomerase; PBH: Prohibitin; PGAM1: Phosphoglycerate mutase 1; PHB2: Prohibitin-2; pkg: protein KINASE G; PLA2: Phospholipases A2; PRDX2: Peroxiredoxin-2; PRDX6: Peroxiredoxin-6; SET: Protein SET; SOD1: Superoxide dismutase \[Cu-Zn\]; SOD2: Superoxide dismutase \[Mn\], mitochondrial; TALDO1: Transaldolase; TUBB: Tubulin beta chain; TUBB4B: Tubulin beta-4B chain; VIM: Vimentin.
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![Venn diagram analyses for the differentially expressed spots (**A**) and identified proteins (**B**) in response to senescence and/or selenium level variation in young or senescent cells.](antioxidants-07-00019-g006){#antioxidants-07-00019-f006}
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List of proteins identified by tandem mass spectrometry (MS/MS) (either by quadrupole-time-of-flight (Q-TOF) or Orbitrap) from the coomassie blue-stained gel (presented in [Figure 3](#antioxidants-07-00019-f003){ref-type="fig"}).

  Master Spot Number                                                                                              Targets of Senescence   Targets of Selenium in Young Cells   Targets of Selenium in Senescent Cells                                                             
  ------------------------------------------------- ------------------------------------------------------------- ----------------------- ------------------------------------ ---------------------------------------- ---- -------- ------- --------- ------- --------- ------- ---------
  **Proteins Targets Common to Three Conditions**                                                                                                                                                                                                                                 
  754                                               Vinculin                                                      VCL                     Orbitrap                             452                                      15   P18206   2.40    0.01800   2.68    0.01800   3.06    0.00540
  2057                                              Ferritin light chain                                          FTL                     Orbitrap                             422                                      21   P02792   1.91    0.00260   −1.78   0.00046   −3.05   0.00000
  1870                                              Superoxide dismutase \[Mn\], mitochondrial                    SOD2                    Orbitrap                             165                                      5    P04179   1.58    0.00016   −1.64   0.00057   −2.42   0.00086
  1870                                              Ubiquitin carboxyl-terminal hydrolase isozyme L1              UCHL1                   Orbitrap                             197                                      12   P09936   1.58    0.00016   −1.64   0.00057   −2.42   0.00086
  1869                                              Ubiquitin carboxyl-terminal hydrolase isozyme L1              UCHL1                   Q-TOF                                251                                      9    P09936   1.54    0.00010   −1.51   0.00013   −2.34   0.00003
  **Proteins Targets Common to Two Conditions**                                                                                                                                                                                                                                   
  600                                               Glycyl-tRNA synthetase                                        GARS                    Q-TOF                                88                                       4    P41250   1.90    0.00059   −2.09   0.00150           
  600                                               Mitochondrial inner membrane protein                          IMMT                    Q-TOF                                72                                       2    Q16891   1.90    0.00059   −2.09   0.00150           
  579                                               Glycyl-tRNA synthetase                                        GARS                    Orbitrap                             1047                                     47   P41250   1.64    0.00300   −1.63   0.00130           
  579                                               Mitochondrial inner membrane protein                          IMMT                    Orbitrap                             1000                                     45   Q16891   1.64    0.00300   −1.63   0.00130           
  579                                               Vinculin                                                      VCL                     Orbitrap                             940                                      31   P18206   1.64    0.00300   −1.63   0.00130           
  1546                                              Prohibitin-2                                                  PHB2                    Q-TOF                                191                                      6    Q99623   4.48    0.00078                     2.69    0.00140
  789                                               78 kDa glucose-regulated protein                              HSPA5                   Orbitrap                             660                                      22   P11021   2.67    0.00280                     4.47    0.00073
  1500                                              L-lactate dehydrogenase B chain                               LDHB                    Orbitrap                             235                                      6    P07195   2.61    0.00029                     2.33    0.00010
  1500                                              Malate dehydrogenase, cytoplasmic                             MDH1                    Orbitrap                             380                                      15   P40925   −2.61   0.00029                     2.33    0.00010
  761                                               Heat shock cognate 71 kDa protein                             HSPA8                   Orbitrap                             557                                      20   P11142   2.60    0.00540                     1.79    0.01200
  761                                               Stress-70 protein, mitochondrial                              HSPA9                   Orbitrap                             573                                      20   P38646   2.60    0.00540                     1.79    0.01200
  753                                               Gelsolin                                                      GSN                     Orbitrap                             252                                      10   P06396   2.40    0.01100                     2.80    0.00230
  1385                                              Actin, cytoplasmic 1                                          ACTB                    Orbitrap                             184                                      6    P60709   2.33    0.00099                     1.96    0.01500
  1385                                              Translation initiation factor eIF-2B subunit beta             EIF2B2                  Orbitrap                             302                                      9    P49770   2.33    0.00099                     1.96    0.01500
  1382                                              Biliverdin reductase A                                        BLVRA                   Q-TOF                                97                                       5    P53004   2.27    0.00130                     2.14    0.00510
  753                                               Heat shock protein 70 kDa                                     HSPA1A                  Orbitrap                             252                                      7    P08107   2.21    0.01100                     2.80    0.00230
  752                                               Heat shock protein 70 kDa                                     HSPA1A                  Orbitrap                             687                                      24   P08107   2.21    0.01500                     2.50    0.00300
  1503                                              Desmoplakin                                                   DSP                     Orbitrap                             198                                      10   P15924   2.21    0.00190                     1.90    0.00095
  1503                                              L-lactate dehydrogenase B chain                               LDHB                    Orbitrap                             225                                      5    P07195   2.21    0.00190                     1.90    0.00095
  1503                                              Malate dehydrogenase, mitochondrial                           MDH2                    Orbitrap                             172                                      6    P40926   2.21    0.00190                     1.90    0.00095
  1383                                              Elongation factor 2                                           EEF2                    Orbitrap                             260                                      11   P13639   2.15    0.00120                     2.42    0.01200
  1383                                              PDZ domain-containing protein GIPC1                           GIPC1                   Orbitrap                             244                                      7    O14908   2.15    0.00120                     2.42    0.01200
  1383                                              Transaldolase                                                 TALDO1                  Orbitrap                             164                                      5    P37837   2.15    0.00120                     2.42    0.01200
  1837                                              Peroxiredoxin-6                                               PRDX6                   Q-TOF                                214                                      11   P30041   2.04    0.00020                     −1.54   0.01300
  553                                               Neutral alpha-glucosidase                                     GANAB                   Orbitrap                             416                                      15   Q14697   1.85    0.00007                     −1.64   0.00140
  553                                               Programmed cell death 6-interacting protein                   PDCD6IP                 Orbitrap                             482                                      18   Q8WUM4   1.85    0.00007                     −1.64   0.00140
  553                                               Caldesmon                                                     CALD1                   Q-TOF                                365                                      20   Q05682   1.85    0.00007                     −1.64   0.00140
  553                                               Neutral alpha-glucosidase AB                                  GANAB                   Q-TOF                                422                                      20   Q14697   1.85    0.00007                     −1.64   0.00140
  1635                                              Annexin A1                                                    ANXA1                   Orbitrap                             486                                      12   P04083   1.84    0.00096                     −2.54   0.00460
  1635                                              Guanine nucleotide-binding protein subunit beta-2-like 1      GNB2L1                  Orbitrap                             647                                      22   P63244   1.84    0.00096                     −2.54   0.00460
  1635                                              Syntenin-1                                                    SDCBP                   Orbitrap                             747                                      22   O00560   1.84    0.00096                     −2.54   0.00460
  1211                                              Actin, cytoplasmic 2                                          ACTG1                   Q-TOF                                63                                       4    P63261   1.83    0.02500                     1.81    0.00014
  1734                                              Prohibitin                                                    PHB                     Q-TOF                                249                                      10   P35232   1.76    0.00053                     −1.63   0.00160
  1859                                              Ubiquitin carboxyl-terminal hydrolase isozyme L1              UCHL1                   Q-TOF                                119                                      5    P09936   1.69    0.03500                     −2.18   0.00023
  1336                                              3-hydroxyisobutyryl-CoA hydrolase, mitochondrial              HIBCH                   Orbitrap                             181                                      5    Q6NVY1   1.62    0.00014                     −1.69   0.01700
  1336                                              Methionine adenosyltransferase 2 subunit beta                 MAT2B                   Orbitrap                             186                                      4    Q9NZL9   1.62    0.00014                     −1.69   0.01700
  1336                                              Phosphoserine aminotransferase                                PSAT1                   Orbitrap                             261                                      11   Q9Y617   1.62    0.00014                     −1.69   0.01700
  1644                                              Annexin A1                                                    ANXA1                   Q-TOF                                198                                      5    P04083   1.52    0.00520                     −1.91   0.00600
  1644                                              Guanine nucleotide-binding protein subunit beta-2-like 1      GNB2L1                  Q-TOF                                110                                      4    P63244   1.52    0.00520                     −1.91   0.00600
  829                                               Pyruvate kinase isozymes M1/M2                                PKM2                    Q-TOF                                299                                      14   P14618   −1.54   0.00200                     1.70    0.00280
  1486                                              Actin, alpha skeletal muscle                                  ACTA1                   Q-TOF                                259                                      5    P68133   −1.60   0.00190                     1.61    0.00044
  1486                                              Actin, cytoplasmic 2                                          ACTG1                   Q-TOF                                259                                      12   P63261   −1.60   0.00190                     1.61    0.00044
  822                                               Pyruvate kinase isozymes M1/M2                                PKM2                    Q-TOF                                152                                      9    P14618   −1.78   0.00130                     2.59    0.00069
  1381                                              Serine-threonine kinase receptor-associated protein           STRAP                   Orbitrap                             667                                      17   Q9Y3F4   −1.87   0.00004                     1.65    0.02300
  1381                                              Vimentin                                                      VIM                     Orbitrap                             269                                      13   P08670   −1.87   0.00004                     1.65    0.02300
  720                                               Heat shock protein 75 kDa, mitochondrial                      TRAP1                   Q-TOF                                143                                      6    Q12931   −1.89   0.00056                     2.23    0.00120
  729                                               Heat shock protein 71 kDa                                     HSPA8                   Orbitrap                             702                                      24   P11142   −2.01   0.00046                     2.54    0.00110
  729                                               Prelamin-A/C                                                  LMNA                    Orbitrap                             577                                      23   P02545   −2.01   0.00046                     2.54    0.00110
  729                                               Heat shock protein 75 kDa, mitochondrial                      TRAP1                   Orbitrap                             783                                      32   Q12931   −2.01   0.00046                     2.54    0.00110
  2202                                              ADP-ribosylation factor 1                                     ARF1                    Orbitrap                             298                                      9    P00441   −2.18   0.00093                     2.74    0.00160
  2202                                              Cofilin-1                                                     CFL1                    Orbitrap                             193                                      5    P23528   −2.18   0.00093                     2.74    0.00160
  2202                                              Superoxide dismutase \[Cu-Zn\]                                SOD1                    Orbitrap                             399                                      13   P00441   −2.18   0.00093                     2.74    0.00160
  **Proteins Targets of One Condition**                                                                                                                                                                                                                                           
  1836                                              Peroxiredoxin-6                                               PRDX6                   Q-TOF                                197                                      11   P30041   1.80    0.00001                             
  1826                                              Heat shock protein beta-1                                     HSPB1                   Q-TOF                                324                                      11   P04792   1.74    0.00031                             
  1506                                              26S proteasome non-ATPase regulatory subunit 14               PSMD14                  Q-TOF                                139                                      6    O00487   1.73    0.02200                             
  1745                                              Cathepsin D                                                   CTSD                    Q-TOF                                195                                      8    P07339   1.68    0.00002                             
  1422                                              Reticulocalbin-1                                              RCN1                    Q-TOF                                432                                      19   Q15293   1.67    0.00027                             
  1422                                              Vimentin                                                      VIM                     Q-TOF                                68                                       3    P08670   1.67    0.00027                             
  1643                                              Electron transfer flavoprotein subunit alpha, mitochondrial   ETFA                    Orbitrap                             1130                                     47   P13804   1.62    0.00035                             
  1181                                              Eukaryotic initiation factor 4A-I                             EIF4A1                  Q-TOF                                138                                      5    P60842   −1.53   0.00300                             
  748                                               Pyruvate kinase isozymes M1/M2                                PKM2                    Q-TOF                                236                                      7    P14618   −1.59   0.00074                             
  1304                                              Spermine synthase                                             SMS                     Q-TOF                                116                                      5    P52788   −1.62   0.00049                             
  1304                                              Vimentin                                                      VIM                     Q-TOF                                83                                       5    P08670   −1.62   0.00049                             
  1402                                              Transaldolase                                                 TALDO1                  Q-TOF                                279                                      7    P37837   −1.66   0.01100                             
  1274                                              Actin, cytoplasmic 2                                          ACTG1                   Q-TOF                                296                                      9    P63261   −1.76   0.00100                             
  1395                                              Annexin A2                                                    ANXA2                   Q-TOF                                122                                      4    P07355                     2.16    0.00300   2.13    0.00930
  2243                                              Actin-related protein 2/3 complex subunit 5                   ARPC5                   Q-TOF                                175                                      5    O15511                     1.91    0.00230   1.57    0.02100
  1653                                              Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial    ECH1                    Orbitrap                             820                                      21   O15144                     1.53    0.00001           
  1278                                              Protein SET                                                   SET                     Q-TOF                                116                                      3    Q01105                     −1.54   0.00620           
  980                                               Glucose-6-phosphate 1-dehydrogenase                           G6PD                    Q-TOF                                279                                      14   P11413                     −1.57   0.00000           
  1302                                              Sialic acid synthase                                          NANS                    Q-TOF                                208                                      6    Q9NR45                     −1.60   0.00000           
  783                                               78 kDa glucose-regulated protein                              HSPA5                   Orbitrap                             887                                      31   P11021                                       3.00    0.00100
  2045                                              Desmoplakin                                                   DSP                     Q-TOF                                504                                      18   P15924                                       2.87    0.00460
  1124                                              Actin, cytoplasmic 2                                          ACTG1                   Q-TOF                                383                                      14   P63261                                       1.75    0.00380
  1124                                              POTE ankyrin domain family member E                           POTEE                   Q-TOF                                269                                      7    Q6S8J3                                       1.75    0.00380
  2363                                              Actin-related protein 2/3 complex subunit 5-like protein      ARPC5L                  Orbitrap                             961                                      36   Q4R5P2                                       1.73    0.00860
  2363                                              Heat shock protein beta-6                                     HSPB6                   Orbitrap                             554                                      28   O14558                                       1.73    0.00860
  837                                               Catalase                                                      CAT                     Q-TOF                                176                                      9    P04040                                       1.68    0.00940
  837                                               Pyruvate kinase isozymes M1/M2                                PKM2                    Q-TOF                                151                                      6    P14618                                       1.68    0.00940
  1174                                              Fumarate hydratase, mitochondrial                             FH                      Q-TOF                                244                                      5    P07954                                       1.64    0.03400
  1783                                              Endoplasmic reticulum resident protein 29                     ERP29                   Q-TOF                                238                                      7    P30040                                       1.55    0.05000
  1864                                              Ubiquitin carboxyl-terminal hydrolase isozyme L1              UCHL1                   Q-TOF                                121                                      6    P09936                                       −1.50   0.02900
  1786                                              Phosphoglycerate mutase 1                                     PGAM1                   Q-TOF                                65                                       3    P18669                                       −1.53   0.00009
  1779                                              Endoplasmic reticulum resident protein 29                     ERP29                   Orbitrap                             447                                      14   P30040                                       −1.55   0.01100
  1779                                              Beta-hexosaminidase subunit beta                              HEXB                    Orbitrap                             533                                      21   P07686                                       −1.55   0.01100
  1779                                              Nicotinamide *N*-methyltransferase                            NNMT                    Orbitrap                             415                                      19   P40261                                       −1.55   0.01100
  1005                                              Tubulin beta chain                                            TUBB                    Q-TOF                                311                                      10   P07437                                       −1.56   0.00035
  1416                                              Annexin A1                                                    ANXA1                   Q-TOF                                343                                      13   P04083                                       −1.56   0.00500
  1728                                              Cathepsin D                                                   CTSD                    Q-TOF                                175                                      8    P07339                                       −1.56   0.00900
  1261                                              Fructose-bisphosphate aldolase A                              ALDOA                   Q-TOF                                196                                      8    P04075                                       −1.57   0.00380
  1437                                              Glyceraldehyde-3-phosphate dehydrogenase                      GAPDH                   Q-TOF                                222                                      7    P04406                                       −1.61   0.01100
  1225                                              Isocitrate dehydrogenase \[NADP\] cytoplasmic                 IDH1                    Q-TOF                                375                                      14   O75874                                       −1.63   0.02300
  1026                                              Aldehyde dehydrogenase, mitochondrial                         ALDH2                   Q-TOF                                185                                      5    P05091                                       −1.65   0.00004
  1026                                              Xaa-Pro dipeptidase                                           PEPD                    Q-TOF                                184                                      5    P12955                                       −1.65   0.00004
  1026                                              Tubulin beta-4B chain                                         TUBB4B                  Q-TOF                                140                                      6    P68371                                       −1.65   0.00004
  1985                                              Peroxiredoxin-2                                               PRDX2                   Q-TOF                                201                                      10   P32119                                       −1.65   0.00380
  970                                               Protein disulfide-isomerase A3                                PDIA3                   Q-TOF                                409                                      19   P30101                                       −1.70   0.00200
  970                                               Vimentin                                                      VIM                     Q-TOF                                158                                      4    P08670                                       −1.70   0.00200
  1618                                              Annexin A5                                                    ANXA5                   Q-TOF                                175                                      11   P08758                                       −1.71   0.00002
  1182                                              Desmin                                                        DES                     Q-TOF                                415                                      18   P17661                                       −1.77   0.01400
  1182                                              Vimentin                                                      VIM                     Q-TOF                                415                                      18   P08670                                       −1.77   0.01400
  1441                                              Glyceraldehyde-3-phosphate dehydrogenase                      GAPDH                   Q-TOF                                246                                      6    P04406                                       −1.77   0.00650
  1942                                              Glutathione S-transferase P                                   GSTP1                   Q-TOF                                329                                      10   P09211                                       −1.82   0.00094
  1938                                              Glutathione S-transferase P                                   GSTP1                   Orbitrap                             1357                                     40   P09211                                       −1.85   0.00000
  992                                               Vimentin                                                      VIM                     Orbitrap                             2287                                     97   P08670                                       −1.87   0.00400
  1368                                              Actin, cytoplasmic 1                                          ACTB                    Q-TOF                                215                                      8    P60709                                       −2.02   0.00056
  1001                                              Tubulin beta chain                                            TUBB                    Q-TOF                                213                                      6    P07437                                       −2.03   0.00010
  1151                                              Protein disulfide-isomerase                                   P4HB                    Q-TOF                                121                                      3    P07237                                       −2.04   0.00270
  1151                                              Ribonuclease inhibitor                                        RNH1                    Q-TOF                                86                                       3    P13489                                       −2.04   0.00270
  1151                                              Vimentin                                                      VIM                     Q-TOF                                40                                       2    P08670                                       −2.04   0.00270
  1556                                              [l]{.smallcaps}-lactate dehydrogenase B                       LDHB                    Orbitrap                             234                                      7    P07195                                       −2.05   0.00310
  1556                                              Inorganic pyrophosphatase                                     PPA1                    Orbitrap                             376                                      21   Q15181                                       −2.05   0.00310
  1556                                              Tubulin beta-6 chain                                          TUBB6                   Orbitrap                             239                                      8    Q9BUF5                                       −2.05   0.00310
  1436                                              Glyceraldehyde-3-phosphate dehydrogenase                      GAPDH                   Q-TOF                                206                                      6    P04406                                       −2.07   0.00900
  1608                                              Annexin A4                                                    ANXA4                   Q-TOF                                481                                      28   P09525                                       −2.17   0.00011
  1485                                              Annexin A1                                                    ANXA1                   Q-TOF                                108                                      4    P04083                                       −2.26   0.00032
  1485                                              Malate dehydrogenase, cytoplasmic                             MDH1                    Q-TOF                                99                                       3    P40925                                       −2.26   0.00032

Nb: number; Sup/Dpl: Supplemented vs. Depleted.
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###### 

Ingenuity pathway analysis of functional networks affected by replicative senescence.

  Network                                                       Members   Molecules                                                                                                                            Associated Groups or Molecules
  ------------------------------------------------------------- --------- ------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Free radical scavenging, molecular transport, cancer          20        ACTA1, ACTG1, ANXA1, ANXA5, CASP8AP2, CTSD, FDXR, HSPB1, LMNA, PHB2, PHB, PRDX2, PRDX6, PSMD14, SMS, SOD1, SOD2, STRAP, TRAP1, VIM   14-3-3, 26S Proteasome, caspase, CD3, Cytochrome c, estrogen receptor, F actin, glutathione peroxidase, hemoglobin, Insulin, Lh, NFkB (complex), Rb, Ubiquitin
  Developmental disorder, neurological and inherited diseases   13        BLVRA, EIF4A1, ETFA, GARS, GNB2L1, IMMT, PKM2, RAB11A, RCN1, TALDO1, TMEM132D, UCHL1, VSP13D                                         AkT, Ap1, CENPI, ERK1/2, FAM189B, FRY, FSH, Histone h3, Jnk, LEMD2, Mapk, NUDT6, P38 MAPK, PDGFB, PI3K (complex), Pkc(s), PTCD2, SLC9A6, SPRED3, UBC, USP35, USP40
  Cancer, neurological disease and cell signaling               1         CEP104                                                                                                                               NR2F6

antioxidants-07-00019-t003_Table 3

###### 

Ingenuity Pathway Analysis of functional networks affected by selenium in young or senescent cells.

  Network                                                                  Members   Molecules                                                                                                                         Associated Groups or Molecules
  ------------------------------------------------------------------------ --------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Immune, inflammatory and hematologic diseases                            21        ACTA1, ACTB, ACTG1, ALDH2, ANXA1, ANXA2, ANXA4, ANXA5, DES, FDXR, GADPH, LMNA, P4HB, PHB2, PPA1, RNH1, STRAP, TUBB, TUBB4B, VIM   Actin, alpha actin, alpha tubulin, Ap1, Beta tubulin, CD3, estrogen receptor, F actin, FSH, Insulin, Lh, NFkB (complex), Profilin, Rock
  Cellular Function and Maintenance, energy production, lipid metabolism   12        ALDOA, BLVRA, CAT, FH, IDH1, MDH1, PEPD, PKM2, POTEE/POTEF, PSMD14, TRAP1, VPS13D                                                 26S proteasome, Akt, BLVRB, ERK1/2, Histone H4, IL22R1-IL10R2, INPP4B, Jnk, Jun-GABP, LEMD2, Mapk, N-arachidonylglycine, NUDT6, P38 MAPK, Pkc(s), PSME4, S100A16, SBSN, SLC26A6, SPRED3, TBCE, UBC, Ybx1-ps3
  Cancer, neurological disease and cell signaling                          1         CEP104                                                                                                                            NR2F6

[^1]: These authors contributed equally to the work.
